NFKB1 rs2305160: What Your Genotype Means
The rs2305160 variant is a genetic change located within the NFKB1 gene, which plays a critical role in regulating the body's immune and inflammatory responses. Research has explored its potential influence on how individuals respond to certain immunosuppressive therapies and its association with inflammatory conditions.
What each genotype means
Typical NFKB1 genotype
This genotype represents the most common genetic state for this location in the NFKB1 gene. While research into this specific variant is limited, it is generally considered the baseline against which other variations are compared. Please consult with your clinician or pharmacist regarding any concerns about medication response or immune-related health.
This is the most common genotype observed in most global populations.
Heterozygous variant carrier
You carry one copy of the variant allele, which has been studied for potential associations with altered immune responses and medication sensitivity. The clinical significance of this specific variant remains limited and may be influenced by other genetic or environmental factors. Discuss your health history and any planned immunosuppressive therapies with your healthcare provider.
The minor allele is found in approximately 40% of European populations, making this heterozygous genotype relatively common.
Homozygous variant carrier
You carry two copies of the variant allele, which is associated with potential differences in how your immune system functions or responds to certain immunosuppressive treatments. Because the evidence for this specific variant is limited, its impact on your personal health is not fully established. Always discuss your genetic findings and any medication-related questions with your clinician or pharmacist.
This genotype is present in a significant portion of the population, particularly among those of European ancestry.
Understanding the rs2305160 Variant
The rs2305160 variant is a single nucleotide polymorphism (SNP) situated within the NFKB1 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in a region that may influence the expression or regulation of the NFKB1 gene. While many genetic variants are common and have no observable effect on health, others are studied for their potential to alter biological pathways. Scientists track these variants to understand how subtle differences in our genetic code might contribute to variations in immune function or how our bodies process medications. Because this variant is found in a gene central to immune signaling, it has been a subject of interest in studies examining inflammatory diseases and the efficacy of treatments that modulate the immune system.
The Role of the NFKB1 Gene
The NFKB1 gene provides instructions for creating a protein that is a key component of the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathway. This pathway acts as a master switch for the immune system, controlling the expression of genes involved in inflammation, cell survival, and the immune response to infection. The gene produces a precursor protein called p105, which is processed into a smaller, active subunit known as p50. This active subunit travels to the cell nucleus, where it binds to DNA to turn specific genes on or off. Because this pathway is so fundamental to how the body manages inflammation, disruptions in NFKB1 function—whether through rare, highly damaging mutations or more common variants—can have significant implications for immune regulation and the development of inflammatory disorders.
Research and Evidence Strength
The evidence linking rs2305160 to specific clinical outcomes is currently considered limited. While the NFKB1 gene itself is well-established as a major player in immune health—with certain rare, loss-of-function variants being a primary cause of common variable immunodeficiency (CVID)—the specific impact of the rs2305160 variant is less clear. Some research has investigated its role in the context of pharmacogenomics, looking at whether this variant influences how patients respond to immunosuppressive drugs or their risk of adverse effects during treatment. However, these associations are often complex and may depend on the specific medication, the patient's underlying condition, and other genetic or environmental factors. Because findings can be mixed or specific to certain populations, it is important to view these associations as areas of ongoing scientific inquiry rather than definitive clinical predictors.
Population Frequency
The rs2305160 variant is relatively common, with a minor allele frequency of approximately 0.40 across European populations. This means that a significant portion of the population carries at least one copy of the variant allele, making it a frequent feature of the genetic landscape in these groups. Because it is so common, it is generally considered a normal variation rather than a rare mutation. Understanding its frequency helps researchers design better studies to determine if the variant has a subtle, cumulative effect on health or if its presence is largely neutral for the vast majority of people.
What This Information Means for You
If you have information about your rs2305160 genotype, it is important to understand that this data is for educational purposes only. Genetic variants like this one rarely act in isolation; they are part of a much larger, complex system involving your entire genome, your environment, and your medical history. Having a particular genotype does not constitute a medical diagnosis, nor does it guarantee a specific response to any medication. If you are concerned about how your genetics might influence your health or your response to a prescribed immunosuppressive therapy, the most important step is to discuss this with your clinician or pharmacist. They are best equipped to interpret your genetic information in the context of your overall health and can provide guidance on appropriate monitoring or treatment adjustments if necessary.
How common is this variant?
The rs2305160 variant is common, with a minor allele frequency of approximately 0.40 across European populations.
Frequently asked questions
Is rs2305160 a cause of immunodeficiency?
While rare, damaging mutations in the NFKB1 gene are a known cause of common variable immunodeficiency (CVID), the common rs2305160 variant is not considered a primary cause of this condition. It is a common genetic variation that is studied for its potential, subtle influence on immune regulation.
Should I change my medication based on this SNP?
No. You should never change your medication or dosage based on genetic test results without consulting your healthcare provider. Pharmacogenomic associations are complex, and your doctor must consider your full medical history and clinical status before making any treatment decisions.
Does this variant affect my risk of inflammation?
The NFKB1 gene is involved in inflammatory pathways, and some research explores how variants in this gene might influence inflammatory responses. However, the evidence for rs2305160 specifically is limited, and it is not a reliable predictor of individual disease risk.
Where can I find more information about my specific genotype?
You can look up your specific SNP in databases like the NCBI SNP database or ClinVar. However, these resources are technical, and it is best to discuss any findings with a genetic counselor or your primary care physician to understand what they mean for your health.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2305160?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in NFKB1
Common non-coding variant frequently investigated in genetic association studies for autoimmune disorders and complex traits.
This variant was identified as a novel genome-wide significant locus associated with allergy risk in a large-scale meta-analysis.